Skip to main content
Erschienen in: Breast Cancer 6/2016

03.11.2015 | Original Article

A comparison between digital breast tomosynthesis and full-field digital mammography for the detection of breast cancers

verfasst von: Woo Jung Choi, Hak Hee Kim, Sun Young Lee, Eun Young Chae, Hee Jung Shin, Joo Hee Cha, Byung Ho Son, Sei Hyun Ahn, Young-Wook Choi

Erschienen in: Breast Cancer | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate interobserver agreement in full-field digital mammography (FFDM) and digital breast tomosynthesis (DBT) in terms of both lesion detection and characterization, and to evaluate the cancer detection rate of standard two-view FFDM compared to various combinations of DBT.

Materials and methods

Thirty-five women (mean age 59.7; range 50–80 years) with 37 breast cancers who underwent both two-view DBT and two-view FFDM were included. DBT images were obtained using an investigational prototype. We performed interobserver agreement analyses using kappa (k) statistics. The cancer detection rate of various combinations of DBT compared to standard two-view FFDM was estimated using a generalized estimation equation.

Results

There was fair to moderate agreement on detectability (k = 0.59–0.62) in both views of FFDM and DBT, while fair to substantial agreement was found for lesion location (k = 0.52–0.84) and fair to moderate agreement for lesion type (k = 0.46–0.70) and BI-RADS final assessment (k = 0.48–0.69). In generalized estimation equations, standard two-view FFDM was inferior to any combination of DBT. The detection rate ratio was significantly higher in the combined four views of DBT and FFDM compared to standard FFDM (p < 0.046).

Conclusion

Our study showed good agreement in lesion detection and characterization between FFDM and DBT images. Our findings also demonstrated that combining DBT and FFDM is superior in detecting cancer compared to standard FFDM.
Literatur
1.
Zurück zum Zitat Tabar L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer. 2001;91:1724–31.CrossRefPubMed Tabar L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer. 2001;91:1724–31.CrossRefPubMed
2.
Zurück zum Zitat Tabar L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011;260:658–63.CrossRefPubMed Tabar L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011;260:658–63.CrossRefPubMed
3.
Zurück zum Zitat Berg WA. Beyond standard mammographic screening: mammography at age extremes, ultrasound, and MR imaging. Radiol Clin North Am. 2007;45:895–906.CrossRefPubMed Berg WA. Beyond standard mammographic screening: mammography at age extremes, ultrasound, and MR imaging. Radiol Clin North Am. 2007;45:895–906.CrossRefPubMed
4.
Zurück zum Zitat Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356:227–36.CrossRefPubMed Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356:227–36.CrossRefPubMed
5.
Zurück zum Zitat Harvey JA, Bovbjerg VE. Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology. 2004;230:29–41.CrossRefPubMed Harvey JA, Bovbjerg VE. Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology. 2004;230:29–41.CrossRefPubMed
6.
Zurück zum Zitat Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353:1773–83.CrossRefPubMed Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353:1773–83.CrossRefPubMed
7.
Zurück zum Zitat Niklason LT, Christian BT, Niklason LE, Kopans DB, Castleberry DE, Opsahl-Ong BH, et al. Digital tomosynthesis in breast imaging. Radiology. 1997;205:399–406.CrossRefPubMed Niklason LT, Christian BT, Niklason LE, Kopans DB, Castleberry DE, Opsahl-Ong BH, et al. Digital tomosynthesis in breast imaging. Radiology. 1997;205:399–406.CrossRefPubMed
8.
Zurück zum Zitat Andersson I, Ikeda DM, Zackrisson S, Ruschin M, Svahn T, Timberg P, et al. Breast tomosynthesis and digital mammography: a comparison of breast cancer visibility and BIRADS classification in a population of cancers with subtle mammographic findings. Eur Radiol. 2008;18:2817–25.CrossRefPubMed Andersson I, Ikeda DM, Zackrisson S, Ruschin M, Svahn T, Timberg P, et al. Breast tomosynthesis and digital mammography: a comparison of breast cancer visibility and BIRADS classification in a population of cancers with subtle mammographic findings. Eur Radiol. 2008;18:2817–25.CrossRefPubMed
9.
Zurück zum Zitat Gennaro G, Toledano A, di Maggio C, Baldan E, Bezzon E, La Grassa M, et al. Digital breast tomosynthesis versus digital mammography: a clinical performance study. Eur Radiol. 2010;20:1545–53.CrossRefPubMed Gennaro G, Toledano A, di Maggio C, Baldan E, Bezzon E, La Grassa M, et al. Digital breast tomosynthesis versus digital mammography: a clinical performance study. Eur Radiol. 2010;20:1545–53.CrossRefPubMed
10.
Zurück zum Zitat Good WF, Abrams GS, Catullo VJ, Chough DM, Ganott MA, Hakim CM, et al. Digital breast tomosynthesis: a pilot observer study. AJR Am J Roentgenol. 2008;190:865–9.CrossRefPubMed Good WF, Abrams GS, Catullo VJ, Chough DM, Ganott MA, Hakim CM, et al. Digital breast tomosynthesis: a pilot observer study. AJR Am J Roentgenol. 2008;190:865–9.CrossRefPubMed
11.
Zurück zum Zitat Gur D, Abrams GS, Chough DM, Ganott MA, Hakim CM, Perrin RL, et al. Digital breast tomosynthesis: observer performance study. AJR Am J Roentgenol. 2009;193:586–91.CrossRefPubMed Gur D, Abrams GS, Chough DM, Ganott MA, Hakim CM, Perrin RL, et al. Digital breast tomosynthesis: observer performance study. AJR Am J Roentgenol. 2009;193:586–91.CrossRefPubMed
12.
Zurück zum Zitat Wallis MG, Moa E, Zanca F, Leifland K, Danielsson M. Two-view and single-view tomosynthesis versus full-field digital mammography: high-resolution X-ray imaging observer study. Radiology. 2012;262:788–96.CrossRefPubMed Wallis MG, Moa E, Zanca F, Leifland K, Danielsson M. Two-view and single-view tomosynthesis versus full-field digital mammography: high-resolution X-ray imaging observer study. Radiology. 2012;262:788–96.CrossRefPubMed
13.
Zurück zum Zitat Skaane P, Bandos AI, Gullien R, Eben EB, Ekseth U, Haakenaasen U, et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology. 2013;267:47–56.CrossRefPubMed Skaane P, Bandos AI, Gullien R, Eben EB, Ekseth U, Haakenaasen U, et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology. 2013;267:47–56.CrossRefPubMed
14.
Zurück zum Zitat Haas BM, Kalra V, Geisel J, Raghu M, Durand M, Philpotts LE. Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening. Radiology. 2013;269:694–700.CrossRefPubMed Haas BM, Kalra V, Geisel J, Raghu M, Durand M, Philpotts LE. Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening. Radiology. 2013;269:694–700.CrossRefPubMed
15.
Zurück zum Zitat Rose SL, Tidwell AL, Bujnoch LJ, Kushwaha AC, Nordmann AS, Sexton R Jr. Implementation of breast tomosynthesis in a routine screening practice: an observational study. AJR Am J Roentgenol. 2013;200:1401–8.CrossRefPubMed Rose SL, Tidwell AL, Bujnoch LJ, Kushwaha AC, Nordmann AS, Sexton R Jr. Implementation of breast tomosynthesis in a routine screening practice: an observational study. AJR Am J Roentgenol. 2013;200:1401–8.CrossRefPubMed
16.
Zurück zum Zitat Rafferty EA, Park JM, Philpotts LE, Poplack SP, Sumkin JH, Halpern EF, et al. Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: results of a multicenter, multireader trial. Radiology. 2013;266:104–13.CrossRefPubMed Rafferty EA, Park JM, Philpotts LE, Poplack SP, Sumkin JH, Halpern EF, et al. Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: results of a multicenter, multireader trial. Radiology. 2013;266:104–13.CrossRefPubMed
17.
Zurück zum Zitat Svahn TM, Chakraborty DP, Ikeda D, Zackrisson S, Do Y, Mattsson S, et al. Breast tomosynthesis and digital mammography: a comparison of diagnostic accuracy. Br J Radiol. 2012;85:e1074–82.CrossRefPubMedPubMedCentral Svahn TM, Chakraborty DP, Ikeda D, Zackrisson S, Do Y, Mattsson S, et al. Breast tomosynthesis and digital mammography: a comparison of diagnostic accuracy. Br J Radiol. 2012;85:e1074–82.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Mun HS, Kim HH, Shin HJ, Cha JH, Ruppel PL, Oh HY, et al. Assessment of extent of breast cancer: comparison between digital breast tomosynthesis and full-field digital mammography. Clin Radiol. 2013;68:1254–9.CrossRefPubMed Mun HS, Kim HH, Shin HJ, Cha JH, Ruppel PL, Oh HY, et al. Assessment of extent of breast cancer: comparison between digital breast tomosynthesis and full-field digital mammography. Clin Radiol. 2013;68:1254–9.CrossRefPubMed
19.
Zurück zum Zitat Gennaro G, Hendrick RE, Ruppel P, Chersevani R, di Maggio C, La Grassa M, et al. Performance comparison of single-view digital breast tomosynthesis plus single-view digital mammography with two-view digital mammography. Eur Radiol. 2013;23:664–72.CrossRefPubMed Gennaro G, Hendrick RE, Ruppel P, Chersevani R, di Maggio C, La Grassa M, et al. Performance comparison of single-view digital breast tomosynthesis plus single-view digital mammography with two-view digital mammography. Eur Radiol. 2013;23:664–72.CrossRefPubMed
21.
Zurück zum Zitat American college of radiology. ACR BI-RADS® Mammography. ACR BI-RADS atlas, breast imaging reporting and data system. 5th. Reston, VA: American college of radiology; 2013. American college of radiology. ACR BI-RADS® Mammography. ACR BI-RADS atlas, breast imaging reporting and data system. 5th. Reston, VA: American college of radiology; 2013.
22.
Zurück zum Zitat Fleiss JL, Cohen J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas. 1973;33:613–9.CrossRef Fleiss JL, Cohen J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas. 1973;33:613–9.CrossRef
23.
Zurück zum Zitat Seigel DG, Podgor MJ, Remaley NA. Acceptable values of kappa for comparison of two groups. Am J Epidemiol. 1992;135:571–8.PubMed Seigel DG, Podgor MJ, Remaley NA. Acceptable values of kappa for comparison of two groups. Am J Epidemiol. 1992;135:571–8.PubMed
24.
Zurück zum Zitat Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121–30.CrossRefPubMed Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121–30.CrossRefPubMed
26.
Zurück zum Zitat Baker JA, Lo JY. Breast tomosynthesis: state-of-the-art and review of the literature. Acad Radiol. 2011;18:1298–310.CrossRefPubMed Baker JA, Lo JY. Breast tomosynthesis: state-of-the-art and review of the literature. Acad Radiol. 2011;18:1298–310.CrossRefPubMed
27.
Zurück zum Zitat Skaane P, Bandos AI, Eben EB, Jebsen IN, Krager M, Haakenaasen U, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014;271:655–63.CrossRefPubMed Skaane P, Bandos AI, Eben EB, Jebsen IN, Krager M, Haakenaasen U, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014;271:655–63.CrossRefPubMed
28.
Zurück zum Zitat Zuley ML, Guo B, Catullo VJ, Chough DM, Kelly AE, Lu AH, et al. Comparison of two-dimensional synthesized mammograms versus original digital mammograms alone and in combination with tomosynthesis images. Radiology. 2014;271:664–71.CrossRefPubMedPubMedCentral Zuley ML, Guo B, Catullo VJ, Chough DM, Kelly AE, Lu AH, et al. Comparison of two-dimensional synthesized mammograms versus original digital mammograms alone and in combination with tomosynthesis images. Radiology. 2014;271:664–71.CrossRefPubMedPubMedCentral
Metadaten
Titel
A comparison between digital breast tomosynthesis and full-field digital mammography for the detection of breast cancers
verfasst von
Woo Jung Choi
Hak Hee Kim
Sun Young Lee
Eun Young Chae
Hee Jung Shin
Joo Hee Cha
Byung Ho Son
Sei Hyun Ahn
Young-Wook Choi
Publikationsdatum
03.11.2015
Verlag
Springer Japan
Erschienen in
Breast Cancer / Ausgabe 6/2016
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-015-0656-1

Weitere Artikel der Ausgabe 6/2016

Breast Cancer 6/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.